US · Healthcare

Anika Therapeutics Inc (ANIK)

Drug Manufacturers - Specialty & Generic

Anika Therapeutics Inc (ANIK) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ANIK

P/E ratio

18.00

Anika Therapeutics Inc (ANIK) — FAQ

What is ANIK's P/E ratio?

The price-to-earnings (P/E) ratio for Anika Therapeutics Inc (ANIK) is 18.00 (data as of 2026-03-23).

Does Anika Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Anika Therapeutics Inc (ANIK). Check the MyAverix Finance app for the latest dividend data.

What sector is Anika Therapeutics Inc in?

Anika Therapeutics Inc (ANIK) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is ANIK listed on?

ANIK is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)